[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352558-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352558-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comparative-evaluation-of-hmg-family-proteins-and-mir-106a-5p-in-low-grade-non-invasive-and-high-grade-muscle-invasive-papillary-urothelial-carcinoma","Comparative Evaluation of HMG Family Proteins and miR-106a-5p in Low-Grade Non-Invasive and High-Grade Muscle-Invasive Papillary Urothelial Carcinoma","","Urothelial carcinoma (UC) of the bladder presents low- and high-grade papillary forms with different prognoses, yet the molecular links between chromatin proteins and regulatory microRNAs remain insufficiently characterized. This study compared HMGA1, HMGA2, and HMGB1 proteins and miR-106a-5p in low-grade versus high-grade papillary UC using tissue from 80 patients, control tumor-adjacent samples, immunohistochemistry, real-time PCR, and droplet digital PCR. HMGA1 and HMGB1 decreased in low-grade lesions but increased in high-grade disease, while miR-106a-5p was highest in normal urothelium and reduced in cancers, with a strong association to aggressiveness. These molecules are proposed as diagnostic and prognostic biomarkers, with therapeutic target potential requiring further mechanistic work.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comparative-evaluation-of-hmg-family-proteins-and-mir-106a-5p-in-low-grade-non-invasive-and-high-grade-muscle-invasive-papillary-urothelial-carcinoma/352558/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comparative-evaluation-of-hmg-family-proteins-and-mir-106a-5p-in-low-grade-non-invasive-and-high-grade-muscle-invasive-papillary-urothelial-carcinoma/352558.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of comparing HMGA1/HMGA2/HMGB1 with miR-106a-5p in papillary urothelial carcinoma?","Question",{"text":63,"@type":64},"To compare how these proteins and miR-106a-5p are expressed in low-grade versus high-grade papillary urothelial carcinoma, clarifying their relationship to tumor aggressiveness and prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were HMGA family protein expression and miR-106a-5p levels measured?",{"text":68,"@type":64},"HMGA1, HMGA2, and HMGB1 protein expression was assessed by immunohistochemistry, while gene expression was quantified by real-time PCR and miR-106a-5p levels were measured by droplet digital PCR.",{"name":70,"@type":61,"acceptedAnswer":71},"What expression pattern distinguished low-grade from high-grade disease in the study?",{"text":72,"@type":64},"HMGA1 and HMGB1 were reduced in low-grade papillary carcinoma compared with control tissues but increased in high-grade lesions; miR-106a-5p was highest in normal urothelium, slightly decreased in low-grade tumors, and significantly reduced in high-grade cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352558,1790541739,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nComparative Evaluation of HMG Family Proteins and miR-106a-5p in Low-Grade Non-Invasive and High-Grade Muscle-Invasive Papillary Urothelial Carcinoma  \nNatalia Domian 1, Magdalena Smerecza ´nska 1, Małgorzata Mrugacz 2, Grzegorz Młynarczyk 3 and Irena Kasacka 1, *  \n1 Department of Histology and Cytophysiology, Medical University of Białystok, 15-089 Białystok, Poland; [natalia.domian@umb.edu.pl](natalia.domian@umb.edu.pl) (N.D.); [magdalena.smereczanska@umb.edu.pl](magdalena.smereczanska@umb.edu.pl) (M.S.)  \n2 Laboratory of Eye Rehabilitation, Medical University of Białystok, 15-089 Białystok, Poland; [malgorzata.mrugacz@umb.edu.pl](malgorzata.mrugacz@umb.edu.pl)  \n3 Department of Urology, Medical University of Białystok, 15-089 Białystok, Poland; [grzegorz.mlynarczyk@umb.edu.pl](grzegorz.mlynarczyk@umb.edu.pl)  \n* Correspondence: [kasacka@umb.edu.pl](kasacka@umb.edu.pl); Tel.: +48-85-748-54-58  \nAbstract  \nUrothelial carcinoma (UC) of the bladder exhibits low-and high-grade papillary forms with distinct prognoses. High mobility group proteins (HMGA1, HMGA2, HMGB1) and miR- 106a-5p are involved in tumor progression, but their interplay in UC remains incompletely understood. The aim of this study was to compare the expression of these parameters in low-and high-grade papillary UC. Tissue samples from 80 patients (40 low-grade and 40 high-grade) undergoing transurethral resection or cystectomy were analyzed, with control samples consisting of tumor-adjacent tissues without histopathological alterations obtained from the same patients. HMGA1, HMGA2, and HMGB1 protein expression was assessed immunohistochemically. Gene expression was quantified by real-time PCR, and miR-106a-5p levels were measured by droplet digital PCR. Statistical analysis was conducted using Statistica 13.3, applying one-way ANOVA with Tukey’s post hoc test and correlation analysis, with p \u003C 0.05 considered significant. Expression of HMGA1 and HMGB1 was reduced in low-grade papillary urothelial carcinoma compared to control tissues, whereas both proteins were significantly increased in high-grade lesions. HMGA2 expression was minimal in low-grade tumors but partially restored in high-grade tumors. Analysis revealed the highest levels of miR-106a-5p in normal urothelium, slightly decreased in low-grade tumors, and significantly reduced in high-grade cancers. HMG proteins and miR-106a-5p demonstrate distinct expression patterns in low-versus high-grade papillary UC, which correlates with tumor aggressiveness. These molecules may serve as diagnostic and prognostic biomarkers. Their potential as therapeutic targets requires further mechanistic and translational investigation.  \nAcademic Editor: Hiroshi Miyamoto  \nReceived: 22 January 2026  \nRevised: 13 February 2026  \nAccepted: 19 February 2026  \nPublished: 24 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nKeywords: urothelial carcinoma; HMGA1; HMGA2; HMGB1; miR-106a-5p; tumor grading; bladder cancer  \n1. Introduction  \nUrothelial carcinoma (UC) of the urinary bladder is a heterogeneous group of malignant tumors classified based on histopathological features into two major categories: low-grade and high-grade tumors. Grading is a key parameter for both prognosis and  \ntherapy guidance in this group of cancers. The pathogenesis of UC involves complex molecular mechanisms in which aberrant gene expression and alterations in cell regulatory proteins play a key role in tumor progression and metastasis [1–3] .  \nBladder cancer remains a major public health problem worldwide, with urothelial carcinoma accounting for approximately 90% of all bladder tumors. The high rate of relapse and risk of progression justify numerous attempts to develop an optimal, effective, and reproducible classification system for grading papillary urothelial tum","cbCaia6ZzqHT1Gx3","https://ap.wps.com/l/cbCaia6ZzqHT1Gx3","pdf",2652567,14,"English","# Introduction\n## Urothelial carcinoma grading and molecular markers\n## HMG family proteins in cancer biology\n## microRNA miR-106a-5p and tumor progression","[{\"question\":\"What was the purpose of comparing HMGA1/HMGA2/HMGB1 with miR-106a-5p in papillary urothelial carcinoma?\",\"answer\":\"To compare how these proteins and miR-106a-5p are expressed in low-grade versus high-grade papillary urothelial carcinoma, clarifying their relationship to tumor aggressiveness and prognosis.\"},{\"question\":\"How were HMGA family protein expression and miR-106a-5p levels measured?\",\"answer\":\"HMGA1, HMGA2, and HMGB1 protein expression was assessed by immunohistochemistry, while gene expression was quantified by real-time PCR and miR-106a-5p levels were measured by droplet digital PCR.\"},{\"question\":\"What expression pattern distinguished low-grade from high-grade disease in the study?\",\"answer\":\"HMGA1 and HMGB1 were reduced in low-grade papillary carcinoma compared with control tissues but increased in high-grade lesions; miR-106a-5p was highest in normal urothelium, slightly decreased in low-grade tumors, and significantly reduced in high-grade cancers.\"}]","Comparative Evaluation of HMG Family Proteins and miR-106a-5p in Low-Grade Non-Invasive and High-Grade Muscle-Invasive Papillary Urothelial Carcinoma | PDF",1790100249,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/894c25d3391be152321e423092bfa432.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/733da5daf3ca9ce532b366f1c3a02c69.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1328e8293f7ca973b510a0d12d116937.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d226e78e9ee5e246cfc9abe6a4f20853.webp",980,1385]